Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients

Authors: Minichmayr, I. K., Schaeftlein, A., Kuti, J. L., Zeitlinger, M., Kloft, C.

Source: CLINICAL PHARMACOKINETICS. 56(6):617-633

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN383998059&indx=1&recIds=ETOCRN383998059

Population Pharmacokinetics of Cefazolin in Serum and Adipose Tissue From Overweight and Obese Women Undergoing Cesarean Delivery

Authors: Grupper, M., Kuti, J. L., Swank, M. L., Maggio, L., Hughes, B. L., Nicolau, D. P.

Source: JOURNAL OF CLINICAL PHARMACOLOGY. 57(6):712-719

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN384697769&indx=1&recIds=ETOCRN384697769

Population pharmacokinetics of meropenem administered as a prolonged infusion in children with cystic fibrosis

Authors: Pettit, R. S., Neu, N., Cies, J. J., Lapin, C., Muhlebach, M. S., Novak, K. J., Nguyen, S. T., Saiman, L., Nicolau, D. P., Kuti, J. L.

Source: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 71(1):189-195

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN375813323&indx=1&recIds=ETOCRN375813323

Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis
Topic of gatifloxacin (TeqCES Trial)

Authors: Kuti, J. L., Nightingale, C. H., Quintiliani, R., Nicolau, D. P.

Source: DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASES. 44(NO 1):51-58

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN047029697&indx=1&recIds=ETOCCN047029697

Vancomycin serum concentrations do not adequately predict tissue exposure in diabetic patients with mild to moderate limb infections

Authors: Hamada, Y., Kuti, J. L., Nicolau, D. P.

Source: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 70(7):2064-2067

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN370855571&indx=1&recIds=ETOCRN370855571

Presence of infection influences the epithelial lining fluid penetration of oral levofloxacin in adult patients

Authors: Kuti, J. L., Nicolau, D. P.

Source: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 45(5):512-518

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN369630257&indx=1&recIds=ETOCRN369630257

Population pharmacokinetics of the piperacillin component of piperacillin/tazobactam in pediatric oncology patients with fever and neutropenia

Authors: Cies, J. J., Jain, J., Kuti, J. L.

Source: PEDIATRIC BLOOD AND CANCER. 62(3):477-482

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN366283766&indx=1&recIds=ETOCRN366283766

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

Authors: Roberts, J. A., Abdul-Aziz, M. H., Lipman, J., Mouton, J. W., Vinks, A. A., Felton, T. W., Hope, W. W., Farkas, A., Neely, M. N., Schentag, J. J., Drusano, G., Frey, O. R., Theuretzbacher, U., Kuti, J. L.

Source: LANCET INFECTIOUS DISEASES. 14(6):498-509

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN352757769&indx=1&recIds=ETOCRN352757769

Prolonging b-lactam infusion: A review of the rationale and evidence, and guidance for implementation

Authors: MacVane, S. H., Kuti, J. L., Nicolau, D. P.

Source: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 43(2):105-113

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN346652212&indx=1&recIds=ETOCRN346652212

In vitro blood culture bottle inoculation of whole blood with clinically relevant antibiotic concentrations: a word of caution

Authors: Grupper, M., Kuti, J. L., Nicolau, D. P.

Source: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 36(5):917-919

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN383766756&indx=1&recIds=ETOCRN383766756

In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii

Authors: Housman, S. T., Hagihara, M., Nicolau, D. P., Kuti, J. L.

Source: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 68(10):2296-2304

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN343736433&indx=1&recIds=ETOCRN343736433

Comparative Pharmacokinetics, Pharmacodynamics, and Tolerability of Ertapenem 1Gram/Day Administered as a Rapid 5-Minute Infusion versus the Standard 30-Minute Infusion in Healthy Adult Volunteers

Authors: Wiskirchen, D. E., Housman, S. T., Quintiliani, R., Nicolau, D. P., Kuti, J. L.

Source: PHARMACOTHERAPY. 33(3):266-274

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN328546915&indx=1&recIds=ETOCRN328546915

Predicting doripenem susceptibility based on meropenem and imipenem interpretation for Pseudomonas aeruginosa

Authors: Hagihara, M., Kuti, J. L., Nicolau, D. P.

Source: DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 72(3):258-262

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN306693139&indx=1&recIds=ETOCRN306693139

Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States

Authors: Kim, A., Nicolau, D. P., Kuti, J. L.

Source: MYCOSES -BERLIN-. 54(5):e301-e312

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN298244947&indx=1&recIds=ETOCRN298244947

Pharmacodynamic profiling of intravenous antibiotics against prevalent Gram-negative organisms across the globe: the PASSPORT Program-Asia-Pacific Region

Authors: Roberts, J. A., Kwa, A., Montakantikul, P., Gomersall, C., Kuti, J. L., Nicolau, D. P.

Source: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 37(3):225-229

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN288004351&indx=1&recIds=ETOCRN288004351

Optimization of meropenem dosage in the critically ill population based on renal function

Authors: Crandon, J. L., Ariano, R. E., Zelenitsky, S. A., Nicasio, A. M., Kuti, J. L., Nicolau, D. P.

Source: INTENSIVE CARE MEDICINE. 37(4):632-638

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN287386746&indx=1&recIds=ETOCRN287386746

Pharmacodynamics and tolerability of high-dose, prolonged infusion carbapenems in adults with cystic fibrosis - A review of 3 cases

Authors: Bulik, C. C., Quintiliani, R., Samuel Pope, J., Kuti, J. L., Nicolau, D. P.

Source: RESPIRATORY MEDICINE CME. 3(3):146-149

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN282424999&indx=1&recIds=ETOCRN282424999

Correlation between vancomycin and daptomycin MIC values for methicillin-susceptible and methicillin-resistant Staphylococcus aureus by 3 testing methodologies

Authors: Keel, R. A., Sutherland, C. A., Aslanzadeh, J., Nicolau, D. P., Kuti, J. L.

Source: DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 68(3):326-329

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN280376113&indx=1&recIds=ETOCRN280376113

Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections

Authors: Kuti, E. L., Kuti, J. L.

Source: EXPERT OPINION ON DRUG METABOLISM AND TOXICOLOGY. 6(10):1287-1300

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN278282064&indx=1&recIds=ETOCRN278282064

Pharmacodynamic modeling of intravenous antibiotics against gram-negative bacteria collected in the United States

Authors: Koomanachai, P., Bulik, C. C., Kuti, J. L., Nicolau, D. P.

Source: CLINICAL THERAPEUTICS. 32(4):766-779

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN270028832&indx=1&recIds=ETOCRN270028832